National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Latanoprost/Timolol (Fixapost®) HTA ID: 21053

Latanoprost/Timolol (Fixapost®) is indicated in adults (including the elderly) for the reduction of intraocular pressure in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta‐blockers or prostaglandin analogues.

 

NCPE Assessment Process Complete
Rapid review commissioned 16/11/2021
Rapid review completed 06/12/2021
Rapid Review outcome A full HTA is not recommended. The NCPE recommends that Fixapost® not be considered for reimbursement at the submitted price*.

 

*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods Act) 2013.